STERIS plc (NYSE:STE) Shares Sold by Illinois Municipal Retirement Fund


Share on StockTwits

Illinois Municipal Retirement Fund decreased its holdings in shares of STERIS plc (NYSE:STE) by 23.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,673 shares of the medical equipment provider’s stock after selling 5,786 shares during the period. Illinois Municipal Retirement Fund’s holdings in STERIS were worth $3,557,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cresset Asset Management LLC boosted its position in STERIS by 5.0% in the 4th quarter. Cresset Asset Management LLC now owns 1,351 shares of the medical equipment provider’s stock valued at $256,000 after buying an additional 64 shares during the last quarter. Greenleaf Trust lifted its position in shares of STERIS by 5.1% during the fourth quarter. Greenleaf Trust now owns 1,434 shares of the medical equipment provider’s stock worth $272,000 after purchasing an additional 70 shares during the last quarter. Lenox Wealth Advisors LLC lifted its position in shares of STERIS by 46.8% during the fourth quarter. Lenox Wealth Advisors LLC now owns 226 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 72 shares during the last quarter. Fiera Capital Corp lifted its position in shares of STERIS by 3.5% during the fourth quarter. Fiera Capital Corp now owns 2,265 shares of the medical equipment provider’s stock worth $429,000 after purchasing an additional 77 shares during the last quarter. Finally, Strategic Investment Advisors MI lifted its position in shares of STERIS by 5.8% during the fourth quarter. Strategic Investment Advisors MI now owns 1,874 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 102 shares during the last quarter. Institutional investors own 90.01% of the company’s stock.

In related news, VP Julia Madsen sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $215.00, for a total transaction of $215,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.20% of the stock is owned by company insiders.

STE has been the topic of several research analyst reports. Zacks Investment Research cut shares of STERIS from a “buy” rating to a “hold” rating and set a $227.00 price target on the stock. in a research report on Tuesday, April 27th. Raymond James reissued a “hold” rating on shares of STERIS in a report on Wednesday, January 20th. Robert W. Baird raised their target price on shares of STERIS from $200.00 to $230.00 and gave the stock an “outperform” rating in a report on Wednesday, January 13th. Finally, KeyCorp raised their price target on shares of STERIS from $224.00 to $227.00 and gave the company an “overweight” rating in a research note on Wednesday, March 17th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. STERIS presently has a consensus rating of “Buy” and an average target price of $216.80.

Shares of NYSE:STE opened at $213.47 on Tuesday. STERIS plc has a 52 week low of $138.66 and a 52 week high of $216.74. The company has a current ratio of 2.64, a quick ratio of 2.00 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $18.22 billion, a P/E ratio of 43.30 and a beta of 0.59. The firm’s 50 day moving average is $199.31 and its two-hundred day moving average is $189.52.

STERIS (NYSE:STE) last posted its quarterly earnings data on Tuesday, February 2nd. The medical equipment provider reported $1.73 EPS for the quarter, beating the Zacks’ consensus estimate of $1.52 by $0.21. STERIS had a net margin of 13.97% and a return on equity of 14.44%. The business had revenue of $808.90 million for the quarter, compared to analyst estimates of $794.08 million. During the same quarter last year, the business earned $1.45 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Analysts predict that STERIS plc will post 6.03 EPS for the current year.

About STERIS

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: What is operating income?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.